{"schema_version":"secwatch.filing_event.v1","accession":"0001667011-22-000018","form_type":"8-K","ticker":"AIP","cik":"0001667011","company_name":"Arteris, Inc.","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.716699+00:00","generated_at":"2026-06-25T21:45:56.557432+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arteris Q1 revenue $11.8M (+77% YoY); ACV+TTM royalties $52.8M (+26%); guides Q2 rev $11.5-14.5M","bullets":["Revenue $11.8M (+77% YoY); GAAP net loss $6.8M ($0.22/share); non-GAAP net loss $4.4M ($0.14/share).","ACV+TTM royalties $52.8M (+26% YoY); RPO $60.5M (+28% YoY).","Operating loss $6.6M (56% of revenue); non-GAAP op. loss $4.2M (36% of revenue).","Q2 guidance: ACV+TTM royalties $49.5-51.5M, revenue $11.5-14.5M; FY22 revenue $48-52M.","19 design starts in Q1; added 7 active customers; BMW licensed Arteris IP for neural network accelerator."],"urls":{"canonical":"https://secwatch.observer/filing/0001667011-22-000018","json":"https://secwatch.observer/filing/0001667011-22-000018.json","markdown":"https://secwatch.observer/filing/0001667011-22-000018.md","text":"https://secwatch.observer/filing/0001667011-22-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1667011/000166701122000018/0001667011-22-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1667011/000166701122000018/aip-20220510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:45:56.557432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}